Improvement in Adjusted EBITDA
Q3 results showed a meaningful adjusted EBITDA improvement, up 10% year-over-year, with an adjusted EBITDA margin increase of 110 basis points.
Strong Performance in SAS Segment
The SAS segment delivered adjusted EBITDA up almost 20% and an increased margin of 200 basis points, driven by strong performance in healthcare and other categories.
Growth in Filtration Category
Filtration revenues were up almost 6%, with transportation filtration up over 5% due to a healthy pipeline and a focus on the aftermarket and heavy-duty fleet vehicles.
Strategic Investments for Growth
Investments in medical films in the U.K. and specialty tapes in Canada are expected to provide over $35 million in incremental revenue opportunities over the next few years.
Cost Reduction and Streamlining Efforts
The company has reduced its footprint from 48 sites to 35 and decreased outside warehouses by over 25%, expected to improve margins.